Tretinoin improves the anti-cancer response to cyclophosphamide, in a model-selective manner.

"data availability the datasets analysed during the current study are available from the geo repository under accession numbers gse186195 gse182674 gse180618 and gse229021. data availability the datasets analysed during the current study are available from the geo repository under accession numbers gse186195"

"Declarations Ethics approval and consent to participateAll experiments were conducted with animal ethics approval from the Harry Perkins Institute Animal Ethics Committee (AE099 and AE153). This study is in accordance with the ARRIVE guidelines. Consult for publicationNot applicable. Competing interestsW.J.L., R.A.L. and A.K.N. received research funding from Douglas Pharmaceuticals and all the other authors declare no competing interest. Competing interests W.J.L., R.A.L. and A.K.N. received research funding from Douglas Pharmaceuticals and all the other authors declare no competing interest."

"Funding This work was funded by grant 1067113 from the NHMRC and a Faculty of Health & Medical Sciences research grant from the University of Western Australia (UWA). The National Centre for Asbestos Related Diseases is supported by NHMRC Centre of Research Excellence grant #1197652. W.J.L. is funded through NHMRC Investigator Grant 1196605. AKN is funded through NHMRC Investigator Grant 2008104."